Treating cancer
Trea
 | Chair Professor Paul Reynolds | Professor Paul Reynolds is the Clinical Director of Medical Specialties at the Central Adelaide Local Health Network, Senior Consultant Respiratory and Sleep Physician in the RAH Department of Thoracic Medicine, Director of Hanson Institute Basic & Translational Research Program and a Professor and NHMRC Practitioner Fellow in the Department of Medicine at the University of Adelaide. |
 | Immune-based cancer therapies Professor Michael Brown | Professor Brown trained originally as a dual-diploma clinical and laboratory immunologist before becoming a consultant medical oncologist at the Royal Adelaide Hospital Cancer Centre in 1998. His PhD was in gene therapy and cancer immunotherapy, and his laboratory is situated in the Centre for Cancer Biology, SA Pathology and University of South Australia. |
 | Proton therapy Associate Professor Hien Le | Dr Hien Le is a Radiation Oncologist with clinical and research interests in the application of innovative and emerging cancer technologies such as stereotactic ablative body radiotherapy and proton therapy. He is the departmental Head of Research and adjunct Associate Professor at the University of South Australia. Dr Le has been successful in winning multiple competitive grants and is the research supervisor for post-graduate students. |
 | Bowel cancer research Associate Professor Tarik Sammour | Tarik Sammour is a colorectal surgeon at the RAH, Associate Professor of Surgery at the University of Adelaide, Fellow of the Royal Australasian College of Surgeons, and Colorectal Surgical Society of Australia and New Zealand. Tarik then completed Royal Melbourne Hospital and RAH post-fellowship colorectal surgery training, and Houston MD Anderson Cancer Center training in robotic colorectal surgery/advanced colorectal surgical oncology. |
Treating trauma and emergencies
 | Chair Mr Paul Flynn | Paul is Board Director in Finance and Not for Profit sectors and Chief Executive Officer of The Hospital Research Foundation Group; Repat Foundation; Road Home Inc; Australian Centre of Excellence for Post-traumatic Stress; Australian Breast Cancer Research; Kidney, Transplant and Diabetes Research Australia; Centre for Creative Health; Cure for Stroke Australia; BiomeBank; Parkinson’s SA/NT; Laurel Palliative Care Foundation and Australian Heart Research. |
 | Acute stroke Associate Professor Tim Kleinig | Tim Kleinig is Head of the South Australia’s sole Comprehensive Stroke Centre and is the SA Health Telestroke Clinical lead. He is also chair of the SA Stroke Community of Practice and Vice-president of the Stroke Society of Australasia. He has been heavily involved in the recent Australian pivotal acute stroke trials, and continues to be involved in researching acute stroke imaging and treatments, for both intracerebral haemorrhage and ischaemic stroke. |
 | Acute spinal injury Professor Brian Freeman | Professor Brian Freeman is an adult and paediatric spinal surgeon based at the Royal Adelaide Hospital and the Women’s & Children’s Hospital. He has a passion for the management of spinal cord injury and paediatric spinal deformity. He is the Research Director of the Adelaide Spinal Research Group. |
 | Nutrition in ICU patients Professor Marianne Chapman | Marianne Chapman is a Senior Medical Specialist in Intensive Care Medicine at RAH and a Clinical Professor in the School of Medicine at the University of Adelaide. She leads a research group undertaking clinical research to improve outcomes following critical illness and is concentrated on nutrition and gut function in critical illness with the overall aim of improving survival and functional recovery. |
Treating COVID-19
 | Chair
Raymond Spencer | Chair Raymond Spencer is Chair for the Central Adelaide Local Health Network Performance Recovery Taskforce, Chair of SA Health and Medical Research Institute, Global Centre for Modern Ageing and SA Venture Capital Fund Boards. He is a Founding Partner of RSVP Ventures and is Chair or Director in several of its portfolio companies. Raymond was Chair of the SA Economic Development Board and has 40 years of leadership experience in international business. |
 | Whole genome sequencing Dr Lex Leong | Dr Lex Leong is the senior molecular microbiologist at the Public Health and Epidemiology group within SA Pathology. As part of this role, Lex is responsible for translational research to investigate infectious diseases using genomic sequencing technologies and its deployment for communicable disease surveillance and outbreak detection for the South Australian population. |
 | COVID-19 response Dr Rebecca Munt | Dr Rebecca Munt holds a joint appointment between CALHN and the Adelaide Nursing School. She has undertaken numerous research projects, predominately in the area of diabetes, and has disseminated the findings locally, nationally and internationally at conferences and through peer reviewed publications. |
 | SA Study Dr Chuan Kok Lim | Dr Chuan Kok LIM is a clinical virologist and infectious diseases physician at SA Pathology and Royal Adelaide Hospital. He has a research interest in basic and translational virology especially in the field of viral hepatitis, stem cell derived liver organoids, and personalized antiviral testing. |
 | Vaccine Professor Guy Ludbrook | Professor Ludbrook is Professor of Anaesthesia and of Head of Acute Care Medicine at the University of Adelaide. He is a specialist anaesthetist at the RAH, Director of PARC Clinical Research, a RAH based early phase clinical trial unit. He specialises in neuroanaesthesia and postoperative care; is published in pharmacology scientific literature and is involved in planning and management of early phase pharmacological trials, including first-in-human trials of anaesthetic and analgesic drugs and COVID therapies. |
 | Highlight Dr Tom Dodd | Dr Tom Dodd is the Clinical Service Director of SA Pathology and provides expert clinical guidance to the organisation and the health sector. He is passionate about continually improving the performance, quality and safety of SA Pathology services across the public and private sectors. |
Treating Inflammatory disorders
 | Chair
Professor
Katheryn Zietz | Clinical Associate Professor Kathryn Zeitz has over 45 peer reviewed publications her research profile includes patient centred care, acute hospital capacity management and mass gathering medicine.
Most recently returning to Central Adelaide from St Vincent’s Network Sydney she is currently the Executive Director, Clinical Governance. |
 | Scleroderma Professor Susanna Proudman | Susanna Proudman is Director of RAH Rheumatology Unit, member of the Pulmonary Hypertension Society of Australia and New Zealand and is Medical Director of Arthritis Australia. As the immediate past Chair of the Australian Scleroderma Interest Group, she established the Australian Scleroderma Cohort Study and collaborations with national and international experts in scleroderma such as the International Systemic Sclerosis Inception Cohort (INSYNC). |
 | Jumper Ants Vaccine Dr Pravin Hissaria | Dr Pravin Hissaria is a Clinical Immunologist at the RAH and a Senior Lecturer, Adelaide University Department of Medicine. He completed FRCPA (Immunology/Clinical Immunology and Allergy). Dr Hissaria is a member of the Central Adelaide Local Health Network Drug and Therapeutics committee, the South Australian Medicines Evaluation Panel (SAMEP) and the Bellberry Ethics Committee. Dr Hissaria is the author of 64 peer reviewed publications. |
 | Inflammatory Bowel Disorders Professor Jane Andrews | Jane Andrews is Senior Consultant Gastroenterologist, Head of RAH Inflammatory Bowel Disorders (IBD) Service, which diagnoses and manages diseases of the oesophagus, stomach, small and large bowel and the pancreas. Jane and her research team look at the medical and psychological impacts of and how treatments can be best delivered to maintain patients' inflammatory bowel disorders. |